Cytology and human papillomavirus testing on cytobrushing samples from patients with head and neck squamous cell carcinoma.

Abstract:

BACKGROUND:The increasing incidence of human papillomavirus (HPV)-related head and neck squamous cell carcinoma (HNSCC) highlights the need for simple and effective tools to evaluate head and neck lesions and their HPV status. The main objective of the current study was to investigate the association between abnormal cytology and HPV infection, assessed on cytobrushing samples, and histologically confirmed HNSCC. Second, the authors attempted to investigate whether HPV status on cytobrushing samples reflected that of the tumoral tissue. METHODS:A total of 164 samples from HNSCC, nonmalignant lesions, or healthy mucosae of the oral cavity and oropharynx were collected by cytobrushing in PreservCyt solution and evaluated by liquid-based cytology and Linear Array HPV genotyping test. All the findings from the cytologic samples were compared with those from the corresponding histologic samples. RESULTS:Patients with abnormal cytology had a significantly higher risk of having an HNSCC (odds ratio [OR], 9.18; 95% confidence inteval [95% CI], 3.27-26.49). The association was stronger for oral cancer (OR, 10.86; 95% CI, 2.51-51.06) than oropharyngeal cancer (OR, 8.45; 95% CI, 1.62-49.82). HPV positivity in the oropharyngeal cytobrushing was associated with a nearly 5-fold higher risk of having abnormal cytology (OR, 4.57; 95% CI, 1.57-13.57) as well as histologically proven oropharyngeal cancer (OR, 5.09; 95% CI, 1.09-31.61). Comparing the HPV status on cytologic and corresponding histologic samples from patients with HNSCC, we found that 90.4% of the cases were concordant (kappa, 0.796). CONCLUSIONS:Abnormal brushing cytology is strongly associated with a diagnosis of HNSCC, whereas HPV positivity on cytobrushing samples is only associated with oropharyngeal cancer. HPV testing on cytobrushing samples represents a valid option for the assessment of HPV infection in patients with oropharyngeal cancer.

journal_name

Cancer

journal_title

Cancer

authors

Donà MG,Giuliani M,Vocaturo A,Spriano G,Pichi B,Rollo F,Ronchetti L,Covello R,Pescarmona E,Benevolo M

doi

10.1002/cncr.28909

subject

Has Abstract

pub_date

2014-11-15 00:00:00

pages

3477-84

issue

22

eissn

0008-543X

issn

1097-0142

journal_volume

120

pub_type

杂志文章

相关文献

CANCER文献大全
  • Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial.

    abstract:BACKGROUND:A Phase II study with carboplatin, methotrexate, and vinblastine (CAMV) was conducted with patients who had advanced urothelial cancer to investigate the activity and toxicity of carboplatin when used in combination chemotherapy. METHODS:Thirty-six patients with advanced urothelial cancer were treated with ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19940401)73:7<1932::aid-cncr2820

    authors: Boccardo F,Pace M,Guarneri D,Canobbio L,Curotto A,Martorana G

    更新日期:1994-04-01 00:00:00

  • Analysis of the androgen response of 23 patients with agnogenic myeloid metaplasia: the value of chromosomal studies in predicting response and survival.

    abstract::The responses of 23 patients with agnogenic myeloid metaplasia (AMM) to androgen therapy were studied. Various clinical and laboratory parameters were analyzed for their value in determining response to therapy and length of survival. Fifty-seven percent of patients responded, as determined by a sustained increase in ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820115)49:2<308::aid-cncr28204

    authors: Besa EC,Nowell PC,Geller NL,Gardner FH

    更新日期:1982-01-15 00:00:00

  • The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials.

    abstract:BACKGROUND:Patients' estimates of their chances of therapeutic benefit from participation in early phase trials greatly exceed historical data. Ethicists worry that this therapeutic misestimation undermines the validity of informed consent. METHODS:The authors interviewed 45 patients enrolled in phase 1 or 2 oncology ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25201

    authors: Sulmasy DP,Astrow AB,He MK,Seils DM,Meropol NJ,Micco E,Weinfurt KP

    更新日期:2010-08-01 00:00:00

  • Gene expression profiling of inflammatory breast cancer.

    abstract:BACKGROUND:Inflammatory breast cancer (IBC) is a rare but aggressive form of breast cancer. Despite multimodality treatment, the long-term survival rate for patients with IBC has remained inferior at 50%. Until recently, IBC was understudied at the molecular level. Since 2004, new high-throughput molecular profiling te...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.25165

    authors: Bertucci F,Finetti P,Birnbaum D,Viens P

    更新日期:2010-06-01 00:00:00

  • Relationship between CA 125 and progesterone production in women with ovarian carcinoma.

    abstract::CA 125 and steroid production is compared in a group of 48 women with ovarian epithelial carcinoma. The histologic types were I C (n = 20), II C (n = 5), III C (n = 11), or V (n = 12). The number of patients in Stage I was six; Stage II, 11; Stage III, 16; and Stage IV, 15. All patients were naturally or surgically po...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900501)65:9<2058::aid-cncr2820

    authors: Mählck CG,Grankvist K,Kjellgren O,Bäckström T

    更新日期:1990-05-01 00:00:00

  • Costs of cancer along the care continuum: What we can expect based on recent literature.

    abstract:BACKGROUND:Cancer costs should be discussed by patients and providers, but information is not readily available. Results from recently published studies (in the last 5 years) on direct and indirect cancer costs may help guide these discussions. METHODS:The authors reviewed studies published between 2013 and 2017 that ...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.31643

    authors: Pisu M,Henrikson NB,Banegas MP,Yabroff KR

    更新日期:2018-11-01 00:00:00

  • Congenital melanoma with multiple prenatal metastases.

    abstract::A 1.95-kg fetus delivered at 33 weeks' gestational age survived less than 1 hour. Physical examination and autopsy disclosed an enormous, protuberant primary malignant melanoma of the skin, enveloping most of the back. A rim of surrounding hyperpigmented skin proved to be a giant congenital melanocytic nevus (GCMN), f...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870915)60:6<1371::aid-cncr2820

    authors: Schneiderman H,Wu AY,Campbell WA,Forouhar F,Yamase H,Greenstein R,Grant-Kels JM

    更新日期:1987-09-15 00:00:00

  • Angiosarcoma in Japan. A review of 99 cases.

    abstract:BACKGROUND:Angiosarcoma is rare, and information about its clinical features are limited. Therefore, a large scale study of angiosarcoma was performed in Japan. METHODS:Through a nationwide Japanese study, 99 cases of angiosarcoma were collected and their clinicopathologic findings were summarized relative to predispo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19950215)75:4<989::aid-cncr28207

    authors: Naka N,Ohsawa M,Tomita Y,Kanno H,Uchida A,Aozasa K

    更新日期:1995-02-15 00:00:00

  • Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: a phase II trial of Cancer and Leukemia Group B.

    abstract:BACKGROUND:The overexpression of HER-2 occurs in a minority of patients with nonsmall cell lung carcinoma. Trastuzumab, which is a monoclonal antibody to HER-2, is an effective treatment in some women with breast carcinomas that overexpress HER-2, as demonstrated by immunohistochemistry. The objective of this Phase II ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/cncr.20950

    authors: Clamon G,Herndon J,Kern J,Govindan R,Garst J,Watson D,Green M,Cancer and Leukemia Group B.

    更新日期:2005-04-15 00:00:00

  • Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases.

    abstract:BACKGROUND:Little is understood about the factors that influence survival in patients who undergo gamma-knife stereotactic radiosurgery (SRS) for brain metastases. METHODS:Demographic, disease, treatment, and survival data on 334 patients with intracranial metastases who underwent initial SRS from 1998 to 2004 were ab...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22367

    authors: DiLuna ML,King JT Jr,Knisely JP,Chiang VL

    更新日期:2007-01-01 00:00:00

  • Immunologic evaluation of patients with advanced head and neck cancer receiving weekly chemoimmunotherapy.

    abstract::Patients with advanced head and neck cancer have significant reduction in their circulating lymphocyte mass which is reflected in decreased numbers of T cells, Fc receptor cells, and in derangements of T lymphocyte functions, i.e., decreased responsiveness to several dilutions of phytohemagglutinin and lack of develop...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197907)44:1<117::aid-cncr2820440

    authors: Zighelboim J,Dorey F,Parker NH,Calcaterra T,Ward P,Fahey JL

    更新日期:1979-07-01 00:00:00

  • Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation.

    abstract:BACKGROUND:Radiofrequency (RF)-induced tissue coagulation represents a new approach for the thermal destruction of tumors within the liver. The purpose of the current study was to 1) assess technique safety; 2) determine the extent and evolution of induced cellular damage; and 3) correlate the observed pathologic effec...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Goldberg SN,Gazelle GS,Compton CC,Mueller PR,Tanabe KK

    更新日期:2000-06-01 00:00:00

  • A case of multiple myeloma with two subclones producing separately kappa and defective gamma chains.

    abstract::A case of multiple myeloma is described that contained two morphologically identical but immunologically diverse subpopulations. One of the subclones produced only kappa chains, whereas the other contained only gamma chains. Additional immunohistologic investigations revealed production by one of the subpopulations of...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850915)56:6<1392::aid-cncr2820

    authors: Metz K,Leder LD

    更新日期:1985-09-15 00:00:00

  • Biopharmacological considerations for accelerating drug development of deguelin, a rotenoid with potent chemotherapeutic and chemopreventive potential.

    abstract::Deguelin is a rotenoid compound that exists in abundant quantities in the bark, roots, and leaves of the Leguminosae family of plants. An analysis of evidence from both in vitro and in vivo studies suggests that deguelin displays potent anticancer activity against multiple cancer types and exhibits chemopreventive pot...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.32069

    authors: Varughese RS,Lam WS,Marican AABH,Viganeshwari SH,Bhave AS,Syn NL,Wang J,Wong AL,Kumar AP,Lobie PE,Lee SC,Sethi G,Goh BC,Wang L

    更新日期:2019-06-01 00:00:00

  • Gemcitabine-based doublets versus single-agent therapy for elderly patients with advanced nonsmall cell lung cancer: a Literature-based Meta-analysis.

    abstract:BACKGROUND:: Although platinum-based combinations are considered the best option of care for patients with advanced nonsmall cell lung cancer (NSCLC), single-agent therapy is the preferred treatment for older patients. Since the late 1990s, various combinations of third-generation agents (gemcitabine [G], vinorelbine, ...

    journal_title:Cancer

    pub_type: 杂志文章,meta分析

    doi:10.1002/cncr.24207

    authors: Russo A,Rizzo S,Fulfaro F,Adamo V,Santini D,Vincenzi B,Gebbia N,Carreca I

    更新日期:2009-05-01 00:00:00

  • Mediterranean Kaposi's sarcoma in the elderly. A randomized study of oral etoposide versus vinblastine.

    abstract:BACKGROUND:This Phase III trial was performed to compare the roles of oral etoposide and intravenous (i.v.) vinblastine in the treatment of Mediterranean Kaposi's Sarcoma (MEKS) in elderly patients with severe disease (Stages II, Ac/B, III, and IV). PATIENTS AND METHODS:Sixty-five patients were randomized to receive e...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19941115)74:10<2873::aid-cncr282

    authors: Brambilla L,Labianca R,Boneschi V,Fossati S,Dallavalle G,Finzi AF,Luporini G

    更新日期:1994-11-15 00:00:00

  • Expression of Fas antigen (CD95) in peripheral blood lymphocytes and in liver-infiltrating, cytotoxic lymphocytes in patients with hepatocellular carcinoma.

    abstract:BACKGROUND:Fas-expressing cytotoxic T lymphocytes (CTLs) are important antitumor immune effector cells in patients with hepatocellular carcinoma (HCC). The role of transforming growth factor beta 1 (TGF-beta1) in modulating the expression of Fas by CTLs is not known in HCC. The objectives of this study were to characte...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20011015)92:8<2136::aid-cncr1555

    authors: Yuen MF,Hughes RD,Heneghan MA,Langley PG,Norris S

    更新日期:2001-10-15 00:00:00

  • Meningeal carcinomatosis in breast cancer presenting as central hypoventilation: a case report with a brief review of the literature.

    abstract::Meningeal carcinomatosis can appear with a variety of neurologic signs and symptoms. Alterations in respiratory control have not been reported in this syndrome or in neurologic syndromes associated with systemic cancer. The authors report on a case of documented leptomeningeal carcinoma from breast cancer presenting a...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810301)47:5<982::aid-cncr28204

    authors: Marcus FS,Dandolos EM,Friedman MA

    更新日期:1981-03-01 00:00:00

  • Androgen and estrogen receptors in hepatocellular carcinoma and the surrounding liver in women.

    abstract::Androgen receptors (AR) and estrogen receptors (ER) were consecutively assayed for hepatocellular carcinoma (HCC) and the surrounding liver was removed surgically from 19 female patients. Patient age ranged from 43 to 79 years, with an average of 61 +/- 9 years. All patients had underlying liver disease (liver cirrhos...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890101)63:1<112::aid-cncr28206

    authors: Nagasue N,Kohno H,Chang YC,Hayashi T,Utsumi Y,Nakamura T,Yukaya H

    更新日期:1989-01-01 00:00:00

  • Challenges in the recruitment of adolescents and young adults to cancer clinical trials.

    abstract::The adolescent and young adult (AYA) oncology population has seen inferior progress in cancer survival compared with younger children and older adults over the past 25 years. Previously, AYAs had the best survival rates due to the prevalence of highly curable diseases including Hodgkin lymphoma and germ cell tumors, y...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.23060

    authors: Burke ME,Albritton K,Marina N

    更新日期:2007-12-01 00:00:00

  • Giant cell tumors of synovium (Pigmented villonodular synovitis) involving the vertebral column.

    abstract::Giant cell tumors of synovium (pigmented villonodular synovitis) involving the vertebral column recently have been seen in two women: the third and fourth cases to be reported in the English-language literature. Unlike the previously reported cases, both these tumors grew outside the dura and produced symptoms of spin...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860515)57:10<2030::aid-cncr282

    authors: Weidner N,Challa VR,Bonsib SM,Davis CH Jr,Carrol TJ Jr

    更新日期:1986-05-15 00:00:00

  • Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases.

    abstract:BACKGROUND:The Akt/mammalian target of the rapamycin (mTOR) signaling pathway represents a promising target for cancer therapy. The phosphorylation status of Akt and of mTOR's phosphorylation target eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) is often used to assess the activity of Akt and mTOR signaling...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23456

    authors: Akcakanat A,Sahin A,Shaye AN,Velasco MA,Meric-Bernstam F

    更新日期:2008-06-01 00:00:00

  • Cell-cycle-dependent expression of human melanoma membrane antigen analyzed by flow cytometry.

    abstract::Knowledge of tumor antigenic expression is crucial to the design of therapeutic strategy. A murine monoclonal antibody (BE4) against a human melanoma membrane antigen, was used to study the in vitro expression of this antigen. By membrane immunofluorescence, BE4 reacted against 5 of 8 melanoma lines as compared to zer...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850315)55:6<1276::aid-cncr2820

    authors: Leong SP,Bolen JL,Chee DO,Smith VR,Taylor JC,Benfield JR,Klevecz RR

    更新日期:1985-03-15 00:00:00

  • A phase II study of "decrescendo" interleukin-2 plus interferon-alpha-2a in patients with progressive metastatic melanoma after chemotherapy.

    abstract:BACKGROUND:The authors tested a biotherapy regimen involving recombinant interferon-alpha-2a (rIFN-alpha-2a) and recombinant human interleukin-2 (rhIL-2), given in a "decrescendo" schedule over 5 days, for its activity and toxicity in 21 patients who previously had received chemotherapy for advanced melanoma. METHODS:...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:

    authors: Eton O,Buzaid AC,Bedikian AY,Smith TM,Papadopoulos NE,Ellerhorst JA,Hibberts JL,Legha SS,Benjamin RS

    更新日期:2000-04-01 00:00:00

  • Mucin core protein expression in extrahepatic bile duct carcinoma is associated with metastases to the liver and poor prognosis.

    abstract:BACKGROUND:Curative resection does not guarantee long term survival for the patient with extrahepatic bile duct carcinoma because of the possibility of metastases to the liver (LM). Expression of mucin core protein-1 (MUC1), sialyl-Le(x), and sialosyl-Tn in bile duct carcinoma was determined and compared with LM and pr...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19991115)86:10<1966::aid-c

    authors: Takao S,Uchikura K,Yonezawa S,Shinchi H,Aikou T

    更新日期:1999-11-15 00:00:00

  • Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 study.

    abstract:BACKGROUND:Recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) is associated with poor survival. Platinum-based chemotherapy is often a first-line treatment. Pemetrexed has shown single-agent activity in SCCHN and in combination with cisplatin for other tumors. This trial examined the efficacy ...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.27449

    authors: Urba S,van Herpen CM,Sahoo TP,Shin DM,Licitra L,Mezei K,Reuter C,Hitt R,Russo F,Chang SC,Hossain AM,Frimodt-Moller B,Koustenis A,Hong RL

    更新日期:2012-10-01 00:00:00

  • Screening young adult cancer survivors with the PROMIS Depression Short Form (PROMIS-D-SF): Comparison with a structured clinical diagnostic interview.

    abstract:BACKGROUND:The current study was conducted to evaluate the Patient-Reported Outcomes Measurement Information System Depression Short Form (PROMIS-D-SF) as a screening measure for young adult cancer survivors (YACS) compared with a structured diagnostic interview. METHODS:A total of 249 YACS (aged 18-40 years) complete...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.32689

    authors: Recklitis CJ,Blackmon JE,Chang G

    更新日期:2020-04-01 00:00:00

  • A comparison of cancer risk in Crohn's disease and ulcerative colitis.

    abstract::The authors estimated cancer risk among 589 patients hospitalized with Crohn's disease between 1960-1976 by calculating the ratios of observed number of cancers (O) in our hospital sample to the expected number of cancers (E) based on the age- and sex-specific cancer rates of a standard population. The authors then co...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19811215)48:12<2742::aid-cncr282

    authors: Greenstein AJ,Sachar DB,Smith H,Janowitz HD,Aufses AH Jr

    更新日期:1981-12-15 00:00:00

  • Squamous cell carcinoma in situ of the endometrium and fallopian tube as superficial extension of invasive cervical carcinoma.

    abstract::Five cases of squamous cell carcinoma of the cervix associated with widespread squamous cell carcinoma in situ of the endometrial surface are reported. In one case, carcinoma in situ was also found in one fallopian tube in continuity with the cervicoendometrial lesion. A survey of the literature reveals only 20 cases ...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(197808)42:2<570::aid-cncr2820420

    authors: Kanbour AI,Stock RJ

    更新日期:1978-08-01 00:00:00

  • Type Ia glycogenosis associated with hepatocellular carcinoma.

    abstract::The predisposition of preexisting cirrhotic metabolic liver disease to the development of hepatocellular carcinoma is well established. However, the association between glycogenoses (a form of noncirrhotic metabolic liver disease) and the formation of benign and malignant liver tumors is less well known. The sixth cas...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19920315)69:6<1320::aid-cncr2820

    authors: Conti JA,Kemeny N

    更新日期:1992-03-15 00:00:00